CRT 2025

Panel Discussion

Panel Moderator(s)

• 

  Emmanouil S. Brilakis, MD, PhD

  Director, Center for Advanced Coronary Interventions
  Minneapolis Heart Institute
  Minneapolis, Minnesota, United States

  Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Elsevier Publishing: royalties (Ongoing); GE Healthcare: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Hippocrates LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IMDS: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Stallion Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TrueVue Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
• 

  Kevin Croce, MD, PhD

  Director of CTO and Complex PCI Programs
  Brigham and Women's Hospital
  Harvard Medical School
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Kathleen E. Kearney, MD

  Associate Professor
  University of Washington
  SEATTLE, Washington, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Lorenzo Azzalini, MD, PhD, MSc

  Interventional Cardiologist
  University of Washington
  Seattle, Washington, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Gauravpal Singh Gill, MD

  Interventional Cardiologist
  James River Cardiology, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Farouc A. Jaffer, MD, PhD

  Director Coronary Intervention and CTO PCI Program
  Massachusetts General Hospital / Harvard Medical School
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Jaikirshan Khatri, MD

  Director of Cardiac Catheterization Laboratory
  Weill Cornell Medical Center, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Stephane Rinfret, MD, SM

  Director of Complex Coronary Interventions
  Georgia Heart Institute
  Gainesville, Georgia, United States

  Disclosure information not submitted.
• 

  Catalin Toma, MD

  Associate Professor
  University of Pittsburgh Medical Center , Pennsylvania, United States

  Disclosure information not submitted.
• 

  Simon J. Walsh, MD

  Consultant Cardiologist
  Belfast Health and Social Care Trust
  Belfast, Northern Ireland, United Kingdom

  Disclosure information not submitted.
• 

  Brett Wanamaker, MD

  Cardiovascular Medicine Fellow
  University of Michigan
  Ann Arbor, MI, United States

  Disclosure information not submitted.
• 

  Gerald S. Werner, MD, PhD, FSCAI

  Director
  Klinikum Darmstadt GmbH
  Darmstadt, Hessen, Germany

  Disclosure information not submitted.
• 

  Masahisa Yamane, MD

  Senior Advisor
  Saitama Sekishinkai Hospital
  Tokyo, Tokyo, Japan

  Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)
• LY

  Laura Young

  Cleveland Clinic

  Disclosure information not submitted.